Page 2 - தாய்வழி கரு மருந்து நிபுணர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study finds significantly lower mother-to-newborn transfer of anti-SARS-CoV-2 antibodies Pregnant women may be especially vulnerable to developing more severe cases of COVID-19 following SARS-CoV-2 infection, but little is known about their anti-SARS-CoV-2 immune response or how it may affect their offspring. In a study published in JAMA Network Open, a group led by investigators at Massachusetts General Hospital (MGH) provides new insights that could help improve care for these women and their newborns and emphasizes the need for pregnant women to be considered in vaccine rollout plans. The study included 127 pregnant women in their third trimester who received care at three Boston hospitals between April 2 and June 13, 2020. Among the 64 women who tested positive for SARS-CoV-2, investigators detected no virus in maternal or cord blood (despite detection in the women s respiratory system), no signs of the virus in placentas and no evidence of viral transmission to newborns. The

United statesAndrea edlowEmily hendersonHarvard medical schoolMassachusetts general hospitalLead authorMaternal fetal medicine specialistAssistant professorReproductive biologyHarvard medicalஒன்றுபட்டது மாநிலங்களில்எமிலி ஹென்டர்சன்ஹார்வர்ட் மருத்துவ பள்ளிமாசசூசெட்ஸ் ஜநரல் மருத்துவமனைவழி நடத்து நூலாசிரியர்தாய்வழி கரு மருந்து நிபுணர்